Stroke is a leading cause of death and disability worldwide. Early recognition and prompt management can significantly improve patient outcomes. This article aims to provide a comprehensive guide for healthcare professionals to effectively recognize and manage strokes in their early stages.
The hallmark of early stroke recognition is the acronym FAST: Face drooping, Arm weakness, Speech difficulty, and Time to call emergency services. However, other signs such as sudden confusion, trouble seeing, difficulty walking, and severe headache with no known cause should also raise suspicion.
Upon suspicion of a stroke, a swift and thorough neurological examination is essential. Immediate imaging, preferably a non-contrast CT scan, is crucial to differentiate between ischemic and hemorrhagic stroke. Concurrently, stabilizing the patient's vitals and starting IV access should be prioritized.
Ischemic strokes, accounting for about 87% of all strokes, require immediate reperfusion therapy. Administering intravenous thrombolytic therapy within 4.5 hours of symptom onset can help salvage the ischemic penumbra. In selected patients, endovascular thrombectomy may be considered within 6-24 hours.
Hemorrhagic strokes necessitate rapid blood pressure control to prevent further bleeding. Neurosurgical consultation should be sought immediately for potential surgical interventions. Adequate hemostasis and reversal of anticoagulation are also critical.
Early recognition and appropriate management of stroke can drastically improve patient outcomes. By understanding the signs and symptoms of a stroke, initiating prompt diagnostic procedures, and employing effective treatment strategies, healthcare professionals can make a significant impact on the trajectory of this devastating disease.
1.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
New imaging guidelines for head and neck cancers, a step toward practice change
4.
How wildfires pose challenges to cancer care
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy
3.
Geriatric Medicine Through Long-Term Functional Survivorship After Cancer in Older Adults
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Advanced Directions in Oncology and Quality Improvement
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
When Unexplained Bruising May Require Blood Testing
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation